2018 International Bladder Cancer Network

REVIEW UroToday

Viewing 1-20 of 30 articles

IBCN 2018: Longitudinal Assessment of Multiplex Patient-Specific ctDNA Biomarkers in Bladder Cancer for Diagnosis, Surveillance, and Recurrence.

IBCN 2018: RBM10: A New Bladder Tumor Suppressor Gene Involved in Alternative Splicing

IBCN 2018: Transcriptional Activation of Genes and Resistance to Palbociclib

IBCN 2018: Molecular Markers and Clinical Outcome of Radical Cystectomy for Bladder Cancer

IBCN 2018: PD-L1 Assays in Muscle-Invasive Bladder Cancer for First-Line Treatment with Atezolizumab and Pembrolizumab

IBCN 2018: HRAS Mutations in Early-Onset Bladder Cancer

IBCN 2018: PD-L1 Expression According to Five Monoclonal Antibodies in Urothelial Cell Cancer

IBCN 2018: Inhibitors of Metabolic Processes in Bladder Cancer Cells

IBCN 2018: Multispectral Imaging Enables Multiparametric Cystoscopy and Transurethral Resection of Bladder Cancer

IBCN 2018: Inhibition of a G9a/EZH2 Network Triggers an Immune-Mediated Bladder Cancer Regression

IBCN 2018: Bladder Cancer and Therapy from an Immunologist's Perspective

IBCN 2018: Lentiviral Interferon: A Novel Method for Gene Therapy in Bladder Cancer

IBCN 2018: Association of Circulating Tumor -DNA Genomic Alterations with Outcomes in Metastatic Urothelial Carcinoma

IBCN 2018: A Non-Invasive Diagnostic Urine Assay to Safely Reduce the Need for Diagnostic Cystoscopy in Patients Presenting with Hematuria

IBCN 2018: STAG2 Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle Invasive Bladder Cancer

IBCN 2018: Insights in the Role of Chemokines in Cancer Metastasization

IBCN 2018: Consensus Molecular Classification of Muscle-Invasive Bladder Cancer

IBCN 2018: Novel Immune Basal Subtypes to Predict Pathologic Response to Chemotherapy and Survival Benefit in Muscle-Invasive Bladder Cancer

IBCN 2018: Combining DNA-Repair Gene Mutations and Molecular Subtyping for More Accurate Prediction of Outcome after Neoadjuvant

IBCN 2018: Signature Immunohistochemical Classifier of Molecular Subtypes in Bladder Cancer

1
2